Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

29 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/29/3017068/0/en/Vyluma-Announces-Acceptance-of-Drug-Application-for-NVK002-by-China-s-National-Medical-Products-Administration-NMPA.html

18 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/18/2900297/0/en/Vyluma-Meets-with-FDA-on-Atropine-Sulfate-Ophthalmic-Solution-0-01-Under-Development-to-Treat-Pediatric-Myopia.html

29 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/29/2889739/0/en/Vyluma-Announces-Marketing-Authorization-Application-Validation-for-the-European-Union.html

11 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/11/2758185/0/en/Vyluma-Announces-Positive-Results-From-Second-Stage-of-Phase-III-CHAMP-Study-of-NVK002-for-the-Treatment-of-Myopia-in-Children.html

06 Jun 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/06/06/2682640/0/en/Vyluma-Announces-FDA-Acceptance-of-New-Drug-Application-for-NVK002-Its-Novel-Investigational-Treatment-for-Pediatric-Myopia.html

05 Jan 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/01/05/2583512/0/en/Vyluma-to-Present-at-the-41st-Annual-J-P-Morgan-Healthcare-Conference.html
ABOUT THIS PAGE